Relmada Therapeutics, Inc.
RLMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,091 | -$9,866 | -$17,559 | -$18,657 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,608 | $3,473 | $4,481 | $6,718 |
| Change in WC | $4,717 | $25 | -$4,770 | $2,903 |
| Other Non-Cash | -$4,955 | -$33 | -$219 | $236 |
| Operating Cash Flow | -$6,722 | -$6,402 | -$18,067 | -$8,800 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$234 | -$321 | -$488 | -$655 |
| Inv. Sales/Matur. | $6,987 | $7,000 | $15,848 | $12,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $6,753 | $6,679 | $15,360 | $11,345 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$73 | $0 | -$172 |
| Financing Cash Flow | $0 | -$73 | $0 | -$172 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $31 | $204 | -$2,707 | $2,373 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,353 | $1,150 | $3,857 | $1,484 |
| End Cash | $1,384 | $1,353 | $1,150 | $3,857 |
| Free Cash Flow | -$6,722 | -$6,402 | -$18,067 | -$8,800 |